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Abstract
Aims—We tested two aims: 1) The Teachable Moment (TM): whether second hand smoke 
exposure (SHSe) feedback motivates cessation in parents of children with asthma vs. parents of 
healthy children (HC) and 2) whether greater intervention intensity (Enhanced-PAM) produces 
greater cessation than a previously tested intervention (Precaution Adoption Model; PAM).
Design and interventions—Aim 1: Two home visits (asthma education or child wellness), and 
cessation induction using Motivational Interviewing and SHSe feedback. Aim 2: Post home-visits, 
parents with asthmatic children were randomized to PAM (n=171; 6 asthma education calls) or 
Enhanced-PAM (n=170; 6 asthma education/smoking cessation calls + repeat SHSe feedback).
Setting—Rhode Island USA.
Participants—Parents of asthmatic (n=341) or healthy (n=219) children who did not have to 
want to quit smoking to enroll.
Measurements—were given at baseline, 2, 4, 6 and 12 months. Abstinence was bioverified. 
Outcomes were 7-day and 30-day ppa, and SHSe (primary) and asthma morbidity (secondary).
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Findings—Aim 1: The TM was supported: parents of asthmatic children were more than twice as 
likely to achieve 30-day (OR=2.60, 95% CI = 1.22–5.54) and 7-day ppa (OR=2.26, 95% CI=1.13–
4.51) at 2 months (primary endpoint) and have non-detectable levels of SHSe than HCs. Greater 
treatment intensity yielded stronger TM effects (OR=3.60; 95% CI= 1.72–7.55). Aim 2: 
Enhanced-PAM was more likely to achieve 30-day ppa at the primary endpoint, 4-months 
(OR=2.12, 95% CI 1.09–4.12) and improved asthma outcomes vs. PAM.
Conclusions—Smoking cessation interventions (Motivational Interviewing + biomarker 
feedback) appear to motivate smoking cessation more strongly among parents of asthmatic 
children than among parents of healthy children. Increased intervention intensity yields greater 
smoking cessation among parents of asthmatic children and better asthma outcomes.
Keywords
Motivational Interviewing; secondhand smoke; smoking cessation; teachable moment
Secondhand Smoke Exposure (SHSe) increases the risk for asthma (1, 2). Over 40% of 
children are exposed to SHSe (3). Interventions focus on SHSe reduction alone (4–8), 
motivating parental smoking cessation (9, 10), or both approaches (11, 12). Addressing only 
SHSe increases the likelihood that parents remain smokers, reduces the likelihood that SHSe 
reduction is sustained, and increases the risk that children will smoke (13–15). The 
combination of SHSe reduction and smoking cessation may be overwhelming to parents (11) 
and has been shown to be less effective than interventions focusing primarily on parental 
smoking cessation (16).
Our previous studies focused on primarily motivating cessation in parents. Parents of 
children with asthma who, in addition to receiving home-based asthma education, were 
randomized to receive the Precaution Adoption Model intervention (PAM; Motivational 
Interviewing to deliver feedback on child’s SHSe and smokers’ Carbon Monoxide level, and 
cessation induction strategies) or the Behavioral Action Model intervention goal setting and 
cessation strategies) matched on dose and intensity. We hypothesized that SHSe feedback 
would help parents link their smoking to their child’s asthma, based on findings that parents 
are unlikely to spontaneously make this connection (17, 18). PAM achieved higher quit rates 
(19, 20) and showed promising effects on children’s asthma morbidity (19, 21), but effects 
were not sustained (20). One goal of the present study was to test whether the outcomes 
achieved by PAM could be enhanced by increasing intervention dose (additional counseling 
calls), intervention intensity (repeat SHSe feedback), and timing the intervention in close 
temporal proximity to the child’s asthma exacerbation to capitalize on the ‘teachable 
moment.’
Teachable moments (TM) are naturally occurring life transitions or health events that have 
the potential to motivate health behavior change because of greater receptivity to health risk 
messages during periods of heightened health awareness (22). Prior studies have timed their 
interventions to coincide with the TM (23, 24), but none have dismantled the effects of their 
interventions from the effects of the TM. For example, in our own studies, we could not 
ascertain whether the effects of PAM were the result of intervention content or specific to the 
target population (having a child with asthma). A comparison group of parents who receive 
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PAM but who are not undergoing a TM (e.g., parents of healthy children) would help answer 
this question. Further, the PAM intervention may be especially suitable for delivery during a 
TM because of the focus on building motivation to quit smoking (through Motivational 
Interviewing) and increasing perception of risk to the child (through SHSe feedback) among 
smokers not actively seeking treatment or unmotivated to quit smoking.
Most prior studies include only smokers who are motivated to quit smoking. Because nearly 
30% of smokers are not motivated to quit (25), studies that exclude them may suffer from 
recruitment biases (16). In our prior studies, smokers did not have to want to quit smoking to 
enroll; they simply needed to be willing to discuss their smoking during pediatric asthma 
care (19, 20). This resulted in > 40% of our samples not motivated to quit smoking upon 
study entry. Thus, we utilized asthma education as a ‘foot in the door’ to discuss the risks of 
smoking on their child’s asthma and on their own health.
The current study also enrolled all smokers, regardless of motivation to quit smoking. We 
hypothesized that providing an intervention to parents after a TM (e.g., child’s acute asthma 
exacerbation) would motivate smoking cessation and SHSe reduction to a greater extent than 
those not experiencing a TM (i.e., parents of healthy children). We also hypothesized that, 
among the parents of children with asthma, that an intervention that added telephone 
counseling and repeated SHSe feedback (Enhanced-PAM) would outperform our previously 
tested intervention (PAM) in terms of greater cessation, lower SHSe, and improved asthma 
morbidity. We hypothesized that Enhanced-PAM would achieve the best outcomes in both 
aims.
Methods
Participants
Parents of children with asthma were recruited from Emergency Departments and urgent 
care. Parents of healthy children (HCs) were recruited from the community. Participants 
were recruited in Rhode Island, USA and were eligible if they: 1) were primary caregivers 
≥18 years old (i.e., person who spends the most time with the child, ≥ 4 hours per week), 2) 
have a child 3–17 years old, 3) smoked ≥ 3 cigarettes/day for the past year and ≥100 
cigarettes in their lifetime, 3) were not pregnant or planning pregnancy, 4) spoke English, 5) 
had a telephone, and 6) were not currently in smoking cessation treatment. Parents who had 
children with other pulmonary disease (e.g., cystic fibrosis) were excluded.
HCs had children with no asthma diagnosis or other chronic respiratory (e.g., cystic fibrosis) 
or cardiac (e.g., congenital heart disease) condition, and no past year hospitalizations for 
serious acute respiratory illness. Children with >4 ARI episodes or chronic or persistent ARI 
(e.g. chronic allergic rhino-sinusitis or chronic otitis media) were excluded; those with 
outpatient treatment for sub-acute respiratory illness (ARI) were not excluded.
Prospective participants were told that they would be required to accept health education 
visits in their home (asthma for parents of children with asthma or child wellness for HCs) 
and discuss their smoking (although they did not have to want to quit). If they decided to 
quit, they were offered 8 weeks of nicotine patches at no cost. The study was conducted 
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from 2007–2013 and received ethical approval from The Miriam Hospital’s Human Subjects 
Review Board.
Procedure
All participants received: 1) two, 1-hour educational home visits (asthma if their child had 
asthma or wellness if HC) and smoking cessation induction counseling, 2) nicotine patches 
if medically eligible and ready to quit within 30 days, and 3) six, 15-minute calls for four 
months after the home visits. Randomization of asthma participants to PAM or PAM-
Enhanced occurred after the second home visit (Figure 1).
Home Visits (for Aim 1; Teachable Moment)—Parents of children with asthma 
received NIH guideline-based asthma education (26). HCs received child wellness 
counseling (nutrition, physical activity, managing stress, child development, and safety). All 
participants received identical smoking cessation induction counseling using Motivational 
Interviewing (27), which included communication strategies (e.g., open-ended questions, 
reflections, evocation, autonomy promotion) and motivational techniques (costs/benefits of 
quitting, elicit-provide-elicit, typical day, barriers/facilitators of motivation and confidence, 
resolving ambivalence, and values clarification (28)(29, 30). Verbal and graphical feedback 
was provided regarding their 1) Carbon Monoxide level, associated symptoms, and how 
quitting could attenuate disease risk and symptoms and 2) child’s SHSe based on objective 
measurements obtained by passive dosimetry: “Your child breathed in as much smoke as if 
s(he) smoked ‘X’ number of cigarettes last week.” Feedback on SHSe in their home versus 
non-smokers’ homes was also provided. The risks of smoking on their child’s asthma and 
how risks could be attenuated by quitting smoking/SHSe reduction was discussed.
Randomization and Telephone Counseling (for Aim 2; Intervention Intensity)—
After the home visits, parents of children with asthma were randomized by a data manager 
to PAM or Enhanced-PAM using an urn randomization procedure (31, 32), which generated 
the code to create the allocation sequence; condition was conveyed to counselors via 
Microsoft Access and could not be accessed by staff.
Both PAM and Enhanced-PAM received six, 15–20 minute calls regarding asthma symptoms 
and management, for four months after the home visits. Enhanced-PAM additionally 
received smoking cessation (Motivational Interviewing; evocation of change talk; building 
readiness/confidence for change, values clarification) and a second round of SHSe feedback 
(to compare their child’s current levels SHSe with those obtained during the home visits). 
HC’s received six, 15–20 minute counseling calls focused on child wellness for four months 
after the home visits; smoking cessation was not discussed. The number, duration, and 
timing of follow-up phone calls were identical for all groups.
Treatment Fidelity
We followed best practice guidelines for treatment fidelity (33). Trainers were licensed 
Clinical Psychologists, one certified in Motivational Interviewing and the other in Asthma 
Education. Counselors had graduate-level degrees and were trained using didactics, role-
plays, and video. Skill acquisition was determined by intervention delivery with pilot 
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participants. Counselors were guided by a written treatment protocol, sessions were 
audiotaped, and a random 20% were reviewed weekly with counselors. Sessions were coded 
using the Motivational Interviewing Treatment Integrity coding system (version 3.1.1) by 
three coders (blind to condition and outcomes) who completed 40 hours of training (e.g., 
coding standardized transcripts).
Primary Outcome Measures
Participants received $20.00 per completed questionnaire given at baseline and 2, 4, 6 and 
12 months by staff who were blind to treatment condition.
Smoking Status. Expired air carbon monoxide testing (Bedfont, Carbon Monoxide Ecolyzer) 
was used to bioverify self-reported abstinence (≤ 9 parts per million (ppm) = abstinence) at 
all follow-ups; readings > 9ppm were recoded as ‘smoking’ (6–18 participants at each time 
point; no significant differences by group). We defined ‘continuous abstinence’ as self-report 
of no smoking since the previous contact; ‘seven-day point prevalence abstinence’ (7-day 
ppa) as no smoking in the past 7 days, and ‘30-day point prevalence abstinence’ (30-day 
ppa) as no smoking in the past 30 days (34); the latter two measures were our primary 
outcomes. The Fagerstrom Test for Nicotine Dependence (35) measured nicotine 
dependence.
Second Hand Smoke Exposure (SHSe) Second Hand Smoke Exposure (SHSe) was 
objectively measured with two passive nicotine monitors (dosimetry) placed for one week 
during each of the two measurement periods (baseline and after call 5), one in the room in 
which the child spent the most time and one worn by the child. The monitors use nicotine as 
a tracer for ambient SHSe, accurately detect nicotine (36–38) and were analyzed by gas 
chromatography. The limit of detection is 0.005 µg per sample, or 0.02 µg /m3 for weekly 
samples. Blank filters were collected throughout the study; all were < 0.005 µg (limit of 
detection). SHSe outcomes were calculated as a dichotomous variable (Non-detectable <.02 
µg/m3 vs. detectable >= .02 µg/m3). To generate ‘cigarette equivalents” used in the SHSe 
feedback, the nicotine concentration of the child sampler was used together with the normal 
breathing rates of children, the side-stream emissions of nicotine, and the ratio of side-
stream to mainstream emissions of N-nitrosodimethylamine (NDMA), a potent carcinogen, 
to calculate the equivalent number of cigarettes that one would have to smoke to have the 
same intake of NDMA as the passive exposure experienced by the child that week: cigarette 
equivalents = [nicotine] * volume air breathed * SS(NDMA)/MS(NDMA) / SS(nicotine) 
(39). Participants received $10.00 for returning the monitors in good condition.
Parent-reported SHSe was assessed by structured interview designed to evoke reliable 
memory-based reports of smoking during the past 7 days (40, 41). Questions assess the total, 
average, least, and greatest number of cigarettes smoked in the home, car, and away from 
home, by both the participant and others. Point estimates of the typical smoking rate (by 
participants and household members) and boundary estimates (average, least and greatest 
amount of cigarettes smoked during one week) were computed. Higher scores indicate 
greater SHSe.
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Secondary Outcome Measures
Asthma Morbidity was assessed by the number of asthma-related hospitalizations, school 
days missed due to asthma, and days with asthma symptoms, in addition to the Asthma 
Functional Morbidity Scale (alpha = .72; (42, 43)).
Program Satisfaction was assessed with three items (scored on a 1 – 5 scale, not at all to 
very much) regarding the helpfulness of the counselors and program satisfaction.
Analytic Plan
Analyses used SAS 9.3. Analysis of variance (ANOVA) and chi-squares assessed baseline 
differences. Previous trial data was used to power the study. We estimated that we needed 
145 participants per arm to detect ≥ 10 percentage point difference between groups for Aim 
1, and ≥13 percentage point difference between groups for Aim 2. Therefore, this study was 
sufficiently powered. Intent to treat was used for cessation outcomes and analyzed with GEE 
(with robust standard errors). Final models adjusted for child and parent age, cigarettes/day 
and motivation to quit. We compared the results assuming missing=smoking to results using 
multiple imputation for missing smoking outcomes using variables at prior assessments 
(smoking status, motivation, asthma morbidity) and baseline (cigarettes/day and education) 
as predictors of missingness. There were no significant differences between models, so 
missing=smoking analyses are reported. We examined differences in SHSe using 
longitudinal mixed effect modeling and likelihood estimation adjusting for baseline SHSe, 
number household smokers, household ban, and parent and child age. Log transformed 
results did not significantly differ from untransformed results, so the latter are presented. We 
controlled for season due to possible effects on asthma, but it was removed because it did 
not add to model fit or impact estimates. Logistic regression estimated the effects of group 
on the probability of non-detectable levels of objective SHSe at follow-up (<.02). Mixed 
effects models with random intercepts assessed between group differences over time in 
asthma morbidity. Longitudinal models (GEEs for binary outcomes and mixed effects 
models for continuous outcomes) assessed between group differences in the probability of 
hospitalization for asthma, missing ≥ least one day of school for asthma and number of 
symptoms.
Results
Participants (n=560) smoked an average of 15 cigarettes/day, had a mean nicotine 
dependence score of 4.53 (SD=2.35), 40% were not ready to quit, 18% never tried to quit, 
46% lived with another smoker, and 55% had a household smoking ban. Over half were 
raising children on their own, most reported low household income, and 30% had < high 
school education (Table 1). The children (mean age = 6.18 years, SD=5.02) had mild to 
moderate asthma functional impairment. See Figure 1 for study flow.
There were no significant baseline demographic differences between Enhanced-PAM and 
PAM, but there were differences between these groups and HC (Table 1). Rates of Carbon 
Monoxide bioverification were high (2 months: 92.9%; 4 months: 95.9%; 6 months: 98.7%; 
12 months: 85.6%) and > 98% of the dosimeters were analyzed. There were no significant 
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group differences on counseling call completion (Call 1: 96.6%; Call 2: 88.2%, Call 3: 
79.9%, Call 4: 71.7%, Call 5: 78.1%, Call 6: 80.4%), assessment completion (2 month: 
87.9%; 4 month: 84.7%; 6 month: 86.3%; 12 month: 85.2%), or percent who reported 
nicotine patch use since study entry (2 months: 56.8%; 4 months: 58.8%; 6 months: 57.2%; 
12 months: 55.0%).
Motivational Interviewing Adherence
Sixty audiotapes were coded, 20 randomly chosen from each group. Coders had good 
reliability (Global Spirit, ICC = .61 and Empathy, ICC = .67; Reflection to Question Ratio 
ICC = .87, Percent Open Ended Questions ICC = .75, Percent Adherent ICC = .64) with one 
exception (Percent Complex Reflections ICC = .38). For the counselors, the average ratings 
of Spirit (3.63/5), Empathy (3.65/5), and Percent Complex Reflections (M=.45) exceeded 
proficiency thresholds. Several indicators approached proficiency (Reflection to Question 
Ratio = .91, Proficiency = 1; Percent Open Ended Questions = .49, Proficiency = .50) except 
one (Percent Adherent = .71, proficiency = .90). There were no significant group differences 
on Motivational Interviewing indicators.
Teachable Moment Analyses
Smoking cessation (Table 2)—We hypothesized that parents of asthmatic children who 
were randomized to PAM would achieve greater 30- and 7 day ppa than HC at our primary 
outcome point for the TM hypothesis (2-months follow-up). We compared PAM with HC 
because both received the same number and type of contacts, varying only on whether or not 
their child had asthma. PAM was more than twice as likely to achieve 30-day ppa (12.9%) 
than HC (5.0%) (OR=2.60, 95% CI = 1.22–5.54; Table 2) and were also more than twice as 
likely to achieve 7 day ppa (14.6%) than HC (6.39%; OR=2.26, 95% CI: 1.13–4.51).
While the above comparison is the most direct test of the TM (the groups varied only on 
whether or not the child had asthma), we wanted to examine differences between Enhanced 
PAM and HC to determine the effect of receiving a greater dose of treatment and having a 
child with asthma. Enhanced-PAM was more than twice as likely to achieve 7 day PPA 
(OR=2.88, 95% CI=1.45–5.69) and more than three times as likely to achieve 30-day ppa 
(OR=3.60; 95% CI= 1.72–7.55) than HCs at the primary outcome point, after covariate 
adjustment. In addition, Enhanced-PAM was and over five times as likely to be continuously 
abstinent (OR=5.58, 95% CI = 2.08–14.96) than HCs at the primary outcome point.
Self-reported SHSe—After covariate adjustment, PAM had significant reductions over 
time on one SHSe variable, while HC had reductions on four out of the five SHSe variables, 
with a significant group × time interaction (Table 3). Enhanced-PAM showed significant 
within-group decreases in SHSe over time on all five variables and HC showed significant 
within group decreases in SHSe over time on four of the five variables. There was a group × 
time effect, such that Enhanced-PAM showed greater decreases in SHSe over time vs. HC 
for three of the five SHSe variables (Table 3).
Objective SHSe—At baseline, 95.1% of the home monitors (93.6% of PAM and 96.4% of 
HC) and 94.3% of the child monitors (92.3% of PAM and 95.9% of HC) had detectable 
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levels of SHSe with no significant group differences. At follow-up, there were significant 
group differences in detectable levels of SHSe in the home monitors (PAM 92.1% vs. HC 
97.2%, χ2 (df=1)=4.39, p=.04) but not the child monitors (PAM 91.4% vs. HC 95.6%). 
After adjusting for covariates, there were significant between-group differences in the home 
monitors, which parallel unadjusted effects (OR=0.68, 95% CI: .25–0.93).
Comparison between Enhanced-PAM vs. PAM
Smoking cessation outcomes (Table 2)—At the primary endpoint (4 months), 
Enhanced-PAM were more than twice as likely to achieve 30-day ppa vs. PAM (OR=2.12; 
95% CI 1.09–4.12).
Self-reported SHSe—Longitudinal mixed effects models revealed that Enhanced-PAM 
achieved significant reductions of SHSe over time, across all five SHSe variables, after 
covariate adjustment (Table 3). PAM showed significant SHSe reduction over time on only 
one SHSe variable. The Group × Time interaction was not significant.
Objective SHSe—At baseline, 93.8% of home monitors (Enhanced-PAM=94.1%, PAM= 
93.6%) and 92.3% of child monitors (Enhanced-PAM=92.3%; PAM=92.3%) had detectable 
levels of SHSe with no significant between group differences. At follow-up, there were no 
significant between group differences in detectable levels of SHSe in either the home 
(Enhanced-PAM=88.8% vs. PAM=92.1%) or child monitors (Enhanced-PAM=89.5% vs. 
PAM=91.4%).
Secondary Outcomes: Asthma Morbidity—At 6 months, Enhanced-PAM had an 81% 
lower odds of a child asthma hospitalization vs. PAM (OR=0.19, 95% CI: .04–.89). The 
odds of missed school due to asthma was lower for Enhanced-PAM vs. PAM at 2 months 
(OR=.52, 95% CI: .26–1.00), 4 months (OR=.48, 95% CI: .24–.95) and 6 month follow-ups 
(OR=.48, 95% CI: .24–.98). The odds of at least one day with asthma symptoms was lower 
among Enhanced-PAM vs PAM (OR=.61, 95% CI: .39–.96) at the 6 month follow-up. There 
were no significant between-group differences in changes in asthma functional morbidity, 
with both groups decreasing over time (b=−0.07, SE=.004, p<.01).
Program Satisfaction—The percent who gave ratings of ≥4 were: 75.4% (helpfulness of 
speaking with the counselor about smoking) and 85.0% (how helpful program would be to 
other parents), with no significant group differences. In terms of satisfaction with care 
provided by the counselor, 88.6% give ratings ≥4, with the PAM reporting less satisfaction 
than HC (83.1% vs. 92,1%, χ2(1)=6.45, p=0.01).
Discussion
Despite a reduction in overall smoking prevalence, parental smoking and pediatric SHSe 
remain high, particularly among minority and low income families with children with 
asthma (44). The first aim of our study was to assess whether providing an intervention after 
a TM (e.g., child’s acute asthma exacerbation) motivates parental smoking cessation and 
SHSe reduction more than one provided to parents of children who did not experience a TM. 
This hypothesis was supported; the intervention provided to the parents of children with 
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asthma who were randomized to PAM was more than twice as likely to produce 30-and 7-
day ppa vs. the same treatment provided to the parents of healthy children. Stronger effects 
were found among parents of children with asthma who were randomized to receive a more 
intense intervention (Enhanced-PAM). Our previous studies have shown that SHSe feedback 
results in higher quit rates, but it was unclear if the effect was due to the intervention, or 
linked to the fact that the intervention was presented during a TM. Our results suggest that 
SHSe feedback is potentiated within the context of a TM, resulting in greater cessation. To 
our knowledge, no previous studies have tested the prospective effect of the TM on smoking 
cessation.
Our second aim was to test whether the effectiveness of two in-home counseling visits that 
included SHSe feedback (PAM) could be improved with the addition of six counseling calls 
and repeated SHSe feedback (Enhanced-PAM). Enhanced PAM achieved significantly 
greater cessation at the primary outcome point vs. PAM. Although Enhanced PAM achieved 
greater cessation rates than PAM at subsequent time points, differences were not significant. 
It is interesting that the two groups were not significantly different before Enhanced-PAM 
received the extra feedback (2 months) and that the effect of the feedback was not sustained 
beyond the four-months. This could be because PAM was a strong contact control in that 
they did receive one round of SHSe feedback and their phone calls were not a ‘sham’ (i.e., 
focused on asthma education). The PAM calls could have continued to raise awareness of 
the effect of smoking on asthma even though smoking was not discussed. We did not feel 
that it would be ethical to have a ‘sham’ condition given that children with asthma were 
enrolled in the study because they had a recent asthma exacerbation necessitating urgent 
care. Therefore, we believed that ‘minimal’ treatment would involve continued asthma 
education.
Feedback on SHSe has been shown to be effective in other studies (10, 19, 46), but to our 
knowledge, ours is the first to provide repeated SHSe feedback to allow for affirmation for 
those who have made changes and a motivational “boost” for those who have not. Enhanced-
PAM also showed significant reductions in SHSe and in asthma health care utilization and 
school attendance vs. PAM, but not on a measure of asthma functional morbidity. Future 
research should investigate ways of increasing the sustainability of the TM effect and 
identifying its mechanisms. Our results also underscore the need to develop novel 
interventions to motivate cessation in parents of healthy children, including strategies to 
increase parental risk perception. Indeed, one study has shown that parents are more than 
four times likely to quit smoking if they believe that quitting will benefit their children’s 
health (18). Ongoing research using multi-level designs to eliminate SHSe show promise 
(47, 48).
One limitation of our study is the inclusion of some components that might not be feasible 
for routine clinical care (e.g., feedback on SHSe). However, portable methods are currently 
under development (49). Another limitation is that the half-life of Carbon Monoxide is 4–6 
hours, so that 7-and 30-day ppa cannot be verified beyond that time frame.
Despite these limitations, our study is unique in 1) using Motivational Interviewing to 
motivate smoking cessation among parents who are not necessarily motivated to quit and 
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have a child with asthma, 2) using Motivational Interviewing to provide repeated SHSe 
feedback, and 3) conducting prospective assessments of the effect of providing an 
intervention during a TM. We were able to reach a large population of smokers who were 
not motivated to quit because our study employed a ‘foot in the door’ approach (e,g, 
providing families with asthma education or child wellness and integrating smoking 
cessation into these educational approaches). Our population had a high prevalence of risk 
factors that are typically associated with difficulty quitting smoking (e.g. low education, low 
income, single mothers). Despite these factors, we achieved quit rates that were two-five-
fold times greater than spontaneous quit rates (45). Our results show that Motivational 
Interviewing for smoking cessation can be delivered during asthma education to increase 
smoking cessation, that this integrated intervention reduces SHSe and asthma care 
utilization, and that these effects may be potentiated by the TM.
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Figure 1. 
Patient Flow
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Table 1
Demographics and Smoking History by Study Group
ENHANCED-
PAM(n=170)
M(SD) or %
PAM(n=171)
M(SD) or %
HC(n=219)
M(SD) or %
All(N=560)
M(SD) or %
Child Age (yrs)*,2,3 4.88 (4.47) 5.42(4.59) 7.79(5.33) 6.18(5.02)
Parent Age (yrs)*,2,3 34.16(9.94) 34.02(9.77) 37.37(9.94) 35.37(1.00)
% Female 78.24% 81.29% 85.84% 82.14%
% Partnered 44.71% 35.67% 34.70% 38.04%
% Employed 40.59% 45.03% 33.33% 39.11%
% < high school education 33.53% 30.41% 27.85% 30.36%
Income (<25k per year) 71.8% 70.4% 72.5% 71.6%
White, Non-Hispanic 54.12% 46.20% 55.71% 52.32%
African American, Non-Hispanic 20.00% 29.24% 22.83% 23.93%
Hispanic/Latino 15.48% 16.57% 13.76% 15.14%
Other 10.40% 7.99% 7.70% 8.61%
Cigarettes/day*,3 15.59(13.00) 13.37(8.15) 15.74(8.12) 14.99(9.91)
% Ready to Quit in 30 days 61.18% 60.23% 58.90% 60.22%
Never tried to Quit (%) 20.59% 18.71% 15.07% 17.86%
Years Smoked*,3 18.00(10.16) 16.91(9.32) 19.89(9.85) 18.41(9.85)
# 24hr Quit Attempts 2.94(3.04)
Median=2
4.96(13.51)
Median=2
3.76(7.92)
Median=2
3.88(9.13)
Median=2
Fagerstrom Test for Nicotine Dependence*,2,3 4.41(2.36) 3.91(2.31) 5.10(2.25) 4.53(2.35)
% Household Smoking Ban*2,3 61.76% 64.91% 42.20% 55.10%
Asthma Morbidity Score 1.41(0.90) 1.52(0.98) N/A 1.47(0.94)
% Households with >=1 additional smoker 54.71% 45.03% 48.17% 46.11%
*p<.05 for between-group difference. Means (standard deviations) are presented unless noted otherwise. Between-group differences refer to null 
hypothesis that group1=group2=group3.
1p<.05 for difference between Enhanced-PAM and PAM
2p<.05 for difference between Enhanced-PAM and Healthy
3p<.05 for difference between PAM and Healthy
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